Features Screener Stocks Charts
Sign In Sign Up

Aurobindo Pharma Ltd. Income Statement

NSE:AUROPHARMA | PHARMACEUTICALS

Showing 2 of 10 years of data. Sign up free for 3 years, or upgrade for full access.

View Plans

2-year AUROPHARMA income statement snapshot

Hover the chart icon for YoY change.

FY 2024 - FY 2025
Item Chart 2024 2025
Revenue 295.59B 323.46B
Cost of Revenue -126.03B -130.26B
Gross Profit 169.56B 193.19B
Sales, General & Admin -105.56B -121.15B
Operating Income 48.79B 55.55B
Profit Before Tax 43.97B 50.66B
Net Income 31.69B 34.86B
Diluted Shares 585.85M 582.87M
Diluted EPS 54.16 59.81

Values are shown in millions (M) and billions (B). All amounts are in Indian Rupees (₹). EPS is earnings per share.

Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: Mar-2025